Results 91 to 100 of about 3,203 (180)

QSPR analysis of the drugs used to treat renal failure and its complications using degree and modified reverse degree indices. [PDF]

Sci Rep
Godlin JJJ, Radha S.
europepmc   +1 more source

KDM6B enhances anti-PD-L1 immunotherapy efficacy by increasing CD8⁺ T-cell infiltration in colorectal cancer. [PDF]

J Cancer
Xun J, Liu Z, Liu B, Jiang X, Yang H, Liu J, Wang B, Gao R, Zhang A, Wu X, Xi Q, Yu X, Zhang Q.   +12 more
europepmc   +1 more source

Clinical value of serum iPTH, ALP and serum markers levels in patients with secondary hyperparathyroidism receiving paricalcitol combined with cinacalcet. [PDF]

J Med Biochem
Ruifang S, Fadong C, Zengqi X, Xiaozhen L.   +3 more
europepmc   +1 more source

Synthetic Modulators of the Vitamin D Receptor: From Structural Innovation to Disease-Specific Applications. [PDF]

Biomolecules
Nguyen TT, Kurokawa T, Kanemoto Y, Sawada T, Kato S.   +4 more
europepmc   +1 more source

Corrigendum: Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway. [PDF]

Front Pharmacol
Zhang J, Liu T, Xue T, Jia Z.
europepmc   +1 more source

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease

Altres ajuts: AbbVie provided funding for the stage 3/4 and stage 5 studies and was involved in the study designs, study execution, collection, analysis, and interpretation of data, and the writing, review, and approval of the report, as well as the ...
Greenbaum, Larry A., Dell, Katherine M., Lee, Ho-Jin, Dufek, Matthew B., Hoppe, Bernd, Webb, Nicholas J. A., Warady, Bradley A., Linde, Peter, Universitat Autònoma de Barcelona, Lerner, Gary, Ariceta, Gema, Eldred, Ann   +11 more
core  

Discovery Potential Hub Genes and Pathways in Keloid Fibroblast Development Based on Bioinformatics Analysis. [PDF]

Int J Genomics
Zhao B, Zhang W, Yao W, Li X, Yang T, Cheng H, Li X.   +6 more
europepmc   +1 more source

Vitamin D and Uterine Fibroids: Insights into Pathophysiology and Therapeutic Potential.

Endocr Rev
Ciebiera M, Zarychta E, Żeber-Lubecka N, Zgliczyńska M, Włodarczyk M, Massalska D, Corachán A, Ali M, Madueke-Laveaux OS, Al-Hendy A.   +9 more
europepmc   +1 more source

Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024). [PDF]

Kidney Int Rep
Wang M, Xiong HY, Zhu C, Yu X, Jiao J, Tan L, Shen Y, Xu H, Mao J, Zhou J, Jiang XY, Shen Q, Wang F, Huang S, Huang W, Xia ZK, Liu XR, Wang H, Wu YB, Yu L, Tao YH, Gao CL, Li YJ, Sun SZ, Zhang DF, Shao XS, Zhao LJ, Wang X, Dang XQ, Huang HM, Chen Y, Li Q, Zhang AH, Subspecialty Group of Nephrology, the Society of Pediatrics, Chinese Medical Association.   +35 more
europepmc   +1 more source

Solicitud paricalcitol cápsula e inyectable

, 2018
En la revisión de las solicitudes presentadas respecto al medicamento paricalcitol cápsula blanda e inyectable, se observa que los expedientes señalan que existe un vacío terapéutico, y debido a que en el Petitorio Nacional Único de Medicamentos Esenciales (PNUME) se cuenta con medicamentos para el tratamiento de la indicación solicitada; por este ...
openaire   +1 more source